Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Spratt

Showing results (401-410 of 498) with videos related to

Pageof 50
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 3, 2023
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 TrialDaniel E Spratt, Vinnie Y T Liu, Jeff Michalski, et al.
Science Translational Medicine|April 17, 2015
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancerAna Bosch, Zhiqiang Li, Anna Bergamaschi, et al.
European Urology|September 20, 2024
Testosterone Recovery Following Androgen Suppression and Prostate Radiotherapy (TRANSPORT): A Pooled Analysis of Five Randomized Trials from the Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) ConsortiumWee Loon Ong, Tahmineh Romero, Soumyajit Roy, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2021
An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate CancerSoumyajit Roy, Nicholas G Zaorsky, Hilary P Bagshaw, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 24, 2021
An international Delphi consensus for pelvic stereotactic ablative radiotherapy re-irradiationFinbar Slevin, Katharine Aitken, Filippo Alongi, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2016
Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal BleedingJae Y Lee, Stephanie Daignault-Newton, Gerard Heath, et al.
Molecular Cancer Therapeutics|August 16, 2020
Expression of the Androgen Receptor Governs Radiation Resistance in a Subset of Glioblastomas Vulnerable to Antiandrogen TherapyChristian K Werner, Uchechi J Nna, Hanshi Sun, et al.
BJU International|February 1, 2017
Anatomical patterns of recurrence following biochemical relapse after post-prostatectomy salvage radiation therapy: a multi-institutional studyWilliam C Jackson, Neil B Desai, Ahmed E Abugharib, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2018
Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical ProstatectomyR Jeffrey Karnes, Vidit Sharma, Voleak Choeurng, et al.
BMC Cancer|June 15, 2019
A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)Roche Kapoor, Matthew P Deek, Riley McIntyre, et al.
Pageof 50

Showing results (401-410 of 498) with videos related to

Sort By:
Pageof 50
International Journal of Radiation Oncology, Biology, Physics|May 3, 2023
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 TrialDaniel E Spratt, Vinnie Y T Liu, Jeff Michalski, et al.
Science Translational Medicine|April 17, 2015
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancerAna Bosch, Zhiqiang Li, Anna Bergamaschi, et al.
European Urology|September 20, 2024
Testosterone Recovery Following Androgen Suppression and Prostate Radiotherapy (TRANSPORT): A Pooled Analysis of Five Randomized Trials from the Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) ConsortiumWee Loon Ong, Tahmineh Romero, Soumyajit Roy, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2021
An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate CancerSoumyajit Roy, Nicholas G Zaorsky, Hilary P Bagshaw, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 24, 2021
An international Delphi consensus for pelvic stereotactic ablative radiotherapy re-irradiationFinbar Slevin, Katharine Aitken, Filippo Alongi, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2016
Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal BleedingJae Y Lee, Stephanie Daignault-Newton, Gerard Heath, et al.
Molecular Cancer Therapeutics|August 16, 2020
Expression of the Androgen Receptor Governs Radiation Resistance in a Subset of Glioblastomas Vulnerable to Antiandrogen TherapyChristian K Werner, Uchechi J Nna, Hanshi Sun, et al.
BJU International|February 1, 2017
Anatomical patterns of recurrence following biochemical relapse after post-prostatectomy salvage radiation therapy: a multi-institutional studyWilliam C Jackson, Neil B Desai, Ahmed E Abugharib, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2018
Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical ProstatectomyR Jeffrey Karnes, Vidit Sharma, Voleak Choeurng, et al.
BMC Cancer|June 15, 2019
A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)Roche Kapoor, Matthew P Deek, Riley McIntyre, et al.
Pageof 50